Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -48

Accepted - Volume 3

Comment Record
Commentor Dr. Yvonne Villanueva-Russell Date/Time 2002-11-01 15:57:15
Organization Texas A&M University-Commerce
Category Academic

Comments for FDA General
1. General Comments I strongly oppose this study as the risks to young children far away any supposed benefits. If smallpox were a deadly disease with no known cure, and one that absolutely no one could survive after having contracted it, and if the threat of smallpox were imminent (and more serious than a veiled attempt to manipulate the public's view of terrorism and create support for a politically motivated agenda, then I might be more persuaded to condone a study of this nature. Unfortunately, this is another in a horrid history of medicine where the poor, the powerless, and the not-fully educated (via informed consent) are victimized, experimented upon and used a guinea pigs in the name of science.

EC -48